Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00506935 · ClinicalTrials.gov registry record · Phase 1
Assessment of GVG for the Treatment of Methamphetamine Dependence
A Phase 1 study of Methamphetamine Addiction, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- Phase 1
- Development phase
- 17
- Enrollment target
- 1
- Study location
NCT00506935 is a Phase 1 study of Methamphetamine Addiction that has completed, run by Baylor College of Medicine. The registered enrollment target is 17 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00506935, a Phase 1 study of Methamphetamine Addiction, has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 17 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to find out if GVG can reduce drug use and determine safety and effects of GVG when used together with methamphetamine. This study involves staying in the hospital for 21 days. Participants will receive either placebo or GVG, and a limited amount if methamphetamine will be injected on some study days. This study will enroll people that use methamphetamine. Participants will be compensated.
Conditions Studied
Interventions
- DRUG placebo
- DRUG GVG
Study Locations (1)
California
- UCLA - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2006-07 |
| Est. Completion | 2008-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00506935
The ClinicalTrials.gov registry entry for NCT00506935 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Methamphetamine Addiction appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.
NCT00506935 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00506935 about?
NCT00506935 is a clinical study titled "Assessment of GVG for the Treatment of Methamphetamine Dependence". The purpose of this study is to find out if GVG can reduce drug use and determine safety and effects of GVG when used together with methamphetamine. This study involves staying in the hospital for 21 days. Participants will receive either placebo or GVG, and a limited amount if methamphetamine will ...
What is the current status of trial NCT00506935?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 17 participants. The study started on 2006-07. Estimated completion is 2008-06.
What conditions does trial NCT00506935 study?
This clinical trial studies the following conditions: Methamphetamine Addiction.
What interventions are being tested in trial NCT00506935?
The interventions under investigation include: placebo (DRUG), GVG (DRUG).
Who is sponsoring clinical trial NCT00506935?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00506935 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.